Background Mycosis fungoides (MF) and S\ue9zary Syndrome (SS) are the most common cutaneous T\u2010cell lymphomas. MF/SS is accompanied by considerable morbidity from pain, itching and disfigurement. Aim To identify factors associated with poorer health\u2010related quality of life (HRQoL) in newly diagnosed MF/SS patients. Methods Patients enrolled into PROCLIPI (an international observational study in MF/SS) had HRQoL assessed using the Skindex\u201029 questionnaire. Skindex\u201029 scores were analysed in relation to patient\u2010specific and disease\u2010specific characteristics. Results The study population consisted of 237 patients (60\ub73% male) with a median age of 60 years (IQR 49\u201070yrs), of whom 179 had early MF and 58 ha...
Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS) are aggressive lymph...
Context. Cutaneous T-cell lymphoma (CTCL), although rare, is associated with a significant symptom b...
BACKGROUND: Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective...
Background Mycosis fungoides (MF) and Sezary Syndrome (SS) are the most common cutaneous T-cell lymp...
Cutaneous T-cell Lymphoma's (CTCL) are a rare, heterogeneous group of T-cell lymphomas that primaril...
Background Prior quantitative studies have described the diminished health-related quality of life (...
Purpose: Advanced-stage mycosis fungoides (MF; stage IIB to IV) and S\ue9zary syndrome (SS) are aggr...
BACKGROUND: Mycosis fungoides and Sézary syndrome (MF/SS) are rare cutaneous T-cell lymphomas. Thei...
Background: The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is a ...
Background The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study is a p...
Summary Background Patients with cutaneous T‐cell lymphoma (CTCL) often have indolent but symptomati...
BACKGROUND The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is ...
Abstract PURPOSE: Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS...
PURPOSE: Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS) are aggress...
none3Mycosis fungoides (MF) constitutes the most frequent cutaneous T-cell lymphoma. Sezary syndrome...
Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS) are aggressive lymph...
Context. Cutaneous T-cell lymphoma (CTCL), although rare, is associated with a significant symptom b...
BACKGROUND: Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective...
Background Mycosis fungoides (MF) and Sezary Syndrome (SS) are the most common cutaneous T-cell lymp...
Cutaneous T-cell Lymphoma's (CTCL) are a rare, heterogeneous group of T-cell lymphomas that primaril...
Background Prior quantitative studies have described the diminished health-related quality of life (...
Purpose: Advanced-stage mycosis fungoides (MF; stage IIB to IV) and S\ue9zary syndrome (SS) are aggr...
BACKGROUND: Mycosis fungoides and Sézary syndrome (MF/SS) are rare cutaneous T-cell lymphomas. Thei...
Background: The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is a ...
Background The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study is a p...
Summary Background Patients with cutaneous T‐cell lymphoma (CTCL) often have indolent but symptomati...
BACKGROUND The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is ...
Abstract PURPOSE: Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS...
PURPOSE: Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS) are aggress...
none3Mycosis fungoides (MF) constitutes the most frequent cutaneous T-cell lymphoma. Sezary syndrome...
Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS) are aggressive lymph...
Context. Cutaneous T-cell lymphoma (CTCL), although rare, is associated with a significant symptom b...
BACKGROUND: Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective...